The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal ...
SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results